表紙
市場調査レポート

エピジェネティクスの世界市場 - 2020年までの予測:製品 (修飾酵素、DNAポリメラーゼ、アセチラーゼ、メチルトランスフェラーゼ、機器・消耗品、キット、亜硫酸水素塩変換キット、試薬)、研究分野、地域別

Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 259906
出版日 ページ情報 英文 167 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
エピジェネティクスの世界市場 - 2020年までの予測:製品 (修飾酵素、DNAポリメラーゼ、アセチラーゼ、メチルトランスフェラーゼ、機器・消耗品、キット、亜硫酸水素塩変換キット、試薬)、研究分野、地域別 Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020
出版日: 2016年02月01日 ページ情報: 英文 167 Pages
概要

世界のエピジェネティクス市場は、2015年に4億6,960万米ドルに達しました。2020年には8億9,000万米ドルまで拡大する見込みで、2015年〜2020年のCAGR (複合年間成長率) で13.64%の成長が予測されています。

当レポートでは、世界のエピジェネティクス市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界のエピジェネティクス市場の概要
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 エピジェネティクス市場:製品別

  • イントロダクション
  • 酵素
  • 機器・消耗品
  • キット
  • 試薬

第7章 エピジェネティクス市場:研究分野別

  • イントロダクション
  • 発生生物学
  • 創薬
  • 腫瘍学
  • その他の研究分野

第8章 エピジェネティクス市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第9章 競合情勢

  • イントロダクション
  • 戦略概要
  • エピジェネティクス市場の主要企業
  • 競合状況と動向

第10章 企業プロファイル (概要、財務、製品・サービス、戦略・発展など)

  • イントロダクション
  • ABCAM PLC
  • ACTIVE MOTIF
  • DIAGENODE, INC.
  • ILLUMINA, INC.
  • MERCK & CO., INC.
  • NEW ENGLAND BIOLABS
  • QIAGEN N.V.
  • SIGMA-ALDRICH CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • ZYMO RESEARCH CORPORATION

第11章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2775

The epigenetics market is expected to reach USD 890.0 million by 2020 from USD 469.6 million in 2015, at a CAGR of 13.64% between 2015 and 2020. By product, the market includes enzymes, instruments & consumables, kits and reagents. Enzymes are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further subsegmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. Kits are further subsegmented into bisulfite conversion kits, ChIP-seq kits, RNA sequencing kits, whole genomic sequencing kits, 5-hmc and 5-mc analysis kits and other epigenetics kits. Reagents are further subsegmented into antibodies, buffers, histones, magnetic beads, primers and other epigenetics reagents. The kits segment is expected to grow at the highest rate. Based on research areas, the market is segmented into developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada. North America is expected to account for the largest share in the global epigenetics market in 2015. Asia is expected to register the fastest growth.

Market growth is majorly driven by the high prevalence of cancer, increasing R & D funding and increasing intensity of genomic research activities. Other growth factors include increasing application for non-oncology diseases and growing partnership between academic, biotechnology and pharmaceutical companies

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global epigenetics market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development: Product portfolios of the top players in the epigenetics market.
  • Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the epigenetics market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various epigenetics products and services across geographies.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL EPIGENETICS MARKET OVERVIEW
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. EPIGENETICS MARKET SEGMENTATION: BY PRODUCT
    • 5.2.2. EPIGENETICS MARKET SEGMENTATION: BY RESEARCH AREA
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. High prevalence of cancer
      • 5.3.1.2. Growing funding for epigenetics-based research
      • 5.3.1.3. Increasing intensity of research activities in the field of epigenetics
      • 5.3.1.4. Growing application of epigenetics in non-oncology diseases
      • 5.3.1.5. Growth in the number of partnerships between academic institutes and biotechnology & pharmaceutical companies for epigenetic-based products
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High cost of instruments
      • 5.3.2.2. Lack of trained professionals
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging markets to present significant growth opportunities

6. EPIGENETICS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. ENZYMES
    • 6.2.1. DNA-MODIFYING ENZYMES
    • 6.2.2. PROTEIN-MODIFYING ENZYMES
    • 6.2.3. RNA-MODIFYING ENZYMES
  • 6.3. INSTRUMENTS AND CONSUMABLES
    • 6.3.1. MASS SPECTROMETERS
    • 6.3.2. NEXT-GENERATION SEQUENCERS
    • 6.3.3. QPCR
    • 6.3.4. SONICATORS
    • 6.3.5. OTHER EPIGENETICS INSTRUMENTS AND CONSUMABLES
  • 6.4. KITS
    • 6.4.1. BISULFITE CONVERSION KITS
    • 6.4.2. CHIP-SEQ KITS
    • 6.4.3. RNA SEQUENCING KITS
    • 6.4.4. WHOLE-GENOME AMPLIFICATION KITS
    • 6.4.5. 5-HMC AND 5-MC ANALYSIS KITS
    • 6.4.6. OTHER EPIGENETICS KITS
  • 6.5. REAGENTS
    • 6.5.1. ANTIBODIES
    • 6.5.2. BUFFERS
    • 6.5.3. HISTONES
    • 6.5.4. MAGNETIC BEADS
    • 6.5.5. PRIMERS
    • 6.5.6. OTHER EPIGENETICS REAGENTS

7. EPIGENETICS MARKET, BY RESEARCH AREA

  • 7.1. INTRODUCTION
  • 7.2. DEVELOPMENTAL BIOLOGY
  • 7.3. DRUG DISCOVERY
  • 7.4. ONCOLOGY
  • 7.5. OTHER RESEARCH AREAS

8. EPIGENETICS MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
    • 8.2.2. CANADA
  • 8.3. EUROPE
  • 8.4. ASIA
  • 8.5. REST OF THE WORLD (ROW)

9. COMPETITIVE LANDSCAPE

  • 9.1. INTRODUCTION
  • 9.2. STRATEGIC OVERVIEW
  • 9.3. LEADING PLAYERS IN THE EPIGENETICS MARKET
  • 9.4. COMPETITIVE SITUATION AND TRENDS
    • 9.4.1. NEW PRODUCT AND SERVICE LAUNCHES
    • 9.4.2. AGREEMENTS, ALLIANCES, COLLABORATIONS, AND PARTNERSHIPS
    • 9.4.3. ACQUISITIONS
    • 9.4.4. EXPANSIONS
    • 9.4.5. OTHER DEVELOPMENTS

10. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 10.1. INTRODUCTION
  • 10.2. ABCAM PLC
  • 10.3. ACTIVE MOTIF
  • 10.4. DIAGENODE, INC.
  • 10.5. ILLUMINA, INC.
  • 10.6. MERCK & CO., INC.
  • 10.7. NEW ENGLAND BIOLABS
  • 10.8. QIAGEN N.V.
  • 10.9. SIGMA-ALDRICH CORPORATION
  • 10.10. THERMO FISHER SCIENTIFIC, INC.
  • 10.11. ZYMO RESEARCH CORPORATION

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. OTHER DEVELOPMENTS
  • 11.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.5. AVAILABLE CUSTOMIZATIONS
  • 11.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: EPIGENETICS MARKET SNAPSHOT
  • TABLE 2: HIGH PREVALENCE OF CANCER IS A MAJOR FACTOR DRIVING MARKET GROWTH
  • TABLE 3: HIGH COST OF INSTRUMENTS TO RESTRAIN MARKET GROWTH
  • TABLE 4: EMERGING ECONOMIES EXPECTED TO OFFER GROWTH OPPORTUNITIES IN THE COMING YEARS
  • TABLE 5: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION)
  • TABLE 6: EPIGENETICS ENZYMES MARKET SIZE, BY TYPE, 2012-2020 (USD MILLION)
  • TABLE 7: EPIGENETICS ENZYMES MARKET SIZE, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 8: EPIGENETICS MARKET SIZE FOR DNA-MODIFYING ENZYMES, BY TYPE, 2012-2020 (USD MILLION)
  • TABLE 9: EPIGENETICS MARKET SIZE FOR DNA-MODIFYING ENZYMES, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 10: EPIGENETICS MARKET SIZE FOR PROTEIN-MODIFYING ENZYMES, BY TYPE, 2012-2020 (USD MILLION)
  • TABLE 11: EPIGENETICS MARKET SIZE FOR PROTEIN-MODIFYING ENZYMES, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 12: EPIGENETICS MARKET SIZE FOR RNA-MODIFYING ENZYMES, BY TYPE, 2012-2020 (USD MILLION)
  • TABLE 13: EPIGENETICS MARKET SIZE FOR RNA-MODIFYING ENZYMES, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 14: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET SIZE, BY TYPE, 2012-2020 (USD MILLION)
  • TABLE 15: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 16: EPIGENETICS MARKET SIZE FOR MASS SPECTROMETERS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 17: EPIGENETICS MARKET SIZE FOR NEXT-GENERATION SEQUENCERS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 18: EPIGENETICS MARKET SIZE FOR QPCR, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 19: EPIGENETICS MARKET SIZE FOR SONICATORS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 20: EPIGENETICS MARKET SIZE FOR OTHER INSTRUMENTS AND CONSUMABLES, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 21: EPIGENETICS KITS MARKET SIZE, BY TYPE, 2012-2020 (USD MILLION)
  • TABLE 22: EPIGENETICS KITS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 23: EPIGENETICS MARKET SIZE FOR BISULFITE CONVERSION KITS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 24: EPIGENETICS MARKET SIZE FOR CHIP-SEQ KITS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 25: EPIGENETICS MARKET SIZE FOR RNA SEQUENCING KITS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 26: EPIGENETICS MARKET SIZE FOR WHOLE-GENOME AMPLIFICATION KITS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 27: EPIGENETICS MARKET SIZE FOR 5-HMC AND 5-MC ANALYSIS KITS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 28: OTHER EPIGENETICS KITS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 29: EPIGENETICS REAGENTS MARKET SIZE, BY TYPE, 2012-2020 (USD MILLION)
  • TABLE 30: EPIGENETICS REAGENTS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 31: EPIGENETICS MARKET SIZE FOR ANTIBODIES, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 32: EPIGENETICS MARKET SIZE FOR BUFFERS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 33: EPIGENETICS MARKET SIZE FOR HISTONES, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 34: EPIGENETICS MARKET SIZE FOR MAGNETIC BEADS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 35: EPIGENETICS MARKET SIZE FOR PRIMERS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 36: OTHER EPIGENETICS REAGENTS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 37: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012-2020 (USD MILLION)
  • TABLE 38: EPIGENETICS MARKET SIZE FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 39: EPIGENETICS MARKET SIZE FOR DRUG DISCOVERY, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 40: EPIGENETICS MARKET SIZE FOR ONCOLOGY, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 41: EPIGENETICS MARKET SIZE FOR OTHER RESEARCH AREAS, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 42: EPIGENETICS MARKET SIZE, BY REGION, 2012-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: EPIGENETICS MARKET SIZE, BY COUNTRY, 2012-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: EPIGENETICS ENZYME MARKET SIZE, BY TYPE, 2012-2020 (USD MILLION)
  • TABLE 46: NORTH AMERICA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012-2020 (USD MILLION)
  • TABLE 47: NORTH AMERICA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012-2020 (USD MILLION)
  • TABLE 48: U.S.: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION)
  • TABLE 49: U.S.: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION)
  • TABLE 50: U.S.: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012-2020 (USD MILLION)
  • TABLE 51: U.S.: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012-2020 (USD MILLION)
  • TABLE 52: CANADA: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION)
  • TABLE 53: CANADA: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION)
  • TABLE 54: CANADA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012-2020 (USD MILLION)
  • TABLE 55: CANADA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012-2020 (USD MILLION)
  • TABLE 56: EUROPE: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION)
  • TABLE 57: EUROPE: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION)
  • TABLE 58: EUROPE: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012-2020 (USD MILLION)
  • TABLE 59: EUROPE: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012-2020 (USD MILLION)
  • TABLE 60: ASIA: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION)
  • TABLE 61: ASIA: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION)
  • TABLE 62: ASIA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012-2020 (USD MILLION)
  • TABLE 63: ASIA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012-2020 (USD MILLION)
  • TABLE 64: ROW: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012-2020 (USD MILLION)
  • TABLE 65: ROW: EPIGENETICS MARKET SIZE, BY ENZYME, 2012-2020 (USD MILLION)
  • TABLE 66: ROW: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012-2020 (USD MILLION)
  • TABLE 67: ROW: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012-2020 (USD MILLION)
  • TABLE 68: RANK OF COMPANIES IN THE GLOBAL EPIGENETICS MARKET, 2015
  • TABLE 69: MARKET DEVELOPMENTS, 2011-2015
  • TABLE 70: NEW PRODUCT AND SERVICE LAUNCHES , 2011-2015
  • TABLE 71: AGREEMENTS, ALLIANCES, COLLABORATIONS, AND PARTNERSHIPS , 2011-2015
  • TABLE 72: ACQUISITIONS, 2011-2015
  • TABLE 73: EXPANSIONS, 2011-2015
  • TABLE 74: OTHER DEVELOPMENTS, 2011-2015
  • TABLE 75: LIST OF DEVELOPMENTS FOR ABCAM PLC, 2011-2015
  • TABLE 76: LIST OF DEVELOPMENTS FOR ACTIVE MOTIF, 2011-2015
  • TABLE 77: LIST OF DEVELOPMENTS FOR DIAGENODE, INC., 2011-2015
  • TABLE 78: LIST OF DEVELOPMENTS FOR ILLUMINA, INC., 2011-2015
  • TABLE 79: LIST OF DEVELOPMENTS FOR MERCK & CO., INC., 2011-2015
  • TABLE 80: LIST OF DEVELOPMENTS FOR NEW ENGLAND BIOLABS, 2011-2015
  • TABLE 81: LIST OF DEVELOPMENTS FOR QIAGEN N.V., 2011-2015
  • TABLE 82: LIST OF DEVELOPMENTS FOR SIGMA-ALDRICH CORPORATION, 2011-2015
  • TABLE 83: LIST OF DEVELOPMENTS FOR THERMO FISHER SCIENTIFIC, INC., 2011-2015
  • TABLE 84: LIST OF DEVELOPMENTS FOR ZYMO RESEARCH CORPORATION, 2011-2015

LIST OF FIGURES

  • FIGURE 1: EPIGENETICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: EPIGENETICS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: EPIGENETICS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: HIGH PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
  • FIGURE 11: ONCOLOGY SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 12: ASIA TO GROW AT THE HIGHEST RATE IN THE FORECAST PERIOD (2015-2020)
  • FIGURE 13: ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 14: EPIGENETICS MARKET: BY PRODUCT
  • FIGURE 15: EPIGENETICS MARKET: BY RESEARCH AREA
  • FIGURE 16: EPIGENETICS MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
  • FIGURE 17: EPIGENETICS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 18: KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2015
  • FIGURE 19: EPIGENETICS ENZYMES MARKET SEGMENTATION, BY TYPE
  • FIGURE 20: DNA-MODIFYING ENZYMES TO DOMINATE THE EPIGENETICS ENZYMES MARKET IN 2015
  • FIGURE 21: NORTH AMERICA TO FORM THE LARGEST REGIONAL SEGMENT OF THE EPIGENETICS ENZYMES MARKET
  • FIGURE 22: DNA-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE
  • FIGURE 23: PROTEIN-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE
  • FIGURE 24: RNA-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE
  • FIGURE 25: EPIGENETICS INSTRUMENTS & CONSUMABLES MARKET, BY TYPE
  • FIGURE 26: NEXT-GENERATION SEQUENCERS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET IN 2015
  • FIGURE 27: ASIA-THE FASTEST-GROWING REGIONAL MARKET FOR EPIGENETICS INSTRUMENTS AND CONSUMABLES BETWEEN 2015 AND 2020
  • FIGURE 28: EPIGENETICS KITS MARKET SEGMENTATION, BY TYPE
  • FIGURE 29: CHIP-SEQ KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS KITS MARKET IN 2015
  • FIGURE 30: ASIA TO FORM THE FASTEST-GROWING REGIONAL MARKET FOR EPIGENETICS KITS
  • FIGURE 31: EPIGENETICS REAGENTS MARKET SEGMENTATION, BY TYPE
  • FIGURE 32: ANTIBODIES TO FORM THE LARGEST SEGMENT OF THE EPIGENETICS REAGENTS MARKET IN 2020
  • FIGURE 33: NORTH AMERICA HOLDS THE LARGEST SHARE FOR THE EPIGENETICS REAGENTS MARKET BETWEEN 2015 AND 2020
  • FIGURE 34: EPIGENETICS MARKET SEGMENTATION, BY RESEARCH AREA
  • FIGURE 35: ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN 2015
  • FIGURE 36: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY
  • FIGURE 37: NORTH AMERICA EXPECTED TO DOMINATE THE EPIGENETICS MARKET FOR DRUG DISCOVERY DURING THE FORECAST PERIOD
  • FIGURE 38: NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET FOR ONCOLOGY
  • FIGURE 39: NORTH AMERICA TO FORM THE LARGEST REGIONAL SEGMENT OF THE OTHER EPIGENETICS RESEARCH AREAS MARKET
  • FIGURE 40: GLOBAL: ECONOMIC INDICATORS
  • FIGURE 41: EPIGENETICS MARKET SEGMENTATION, BY REGION
  • FIGURE 42: ASIA TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD
  • FIGURE 43: EPIGENETICS MARKET IN ASIA TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020
  • FIGURE 44: NORTH AMERICA: ECONOMIC INDICATORS
  • FIGURE 45: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 46: U.S. FORMS THE FASTEST-GROWING MARKET IN NORTH AMERICA IN 2015
  • FIGURE 47: KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN NORTH AMERICA IN 2015
  • FIGURE 48: DNA-MODIFYING ENZYMES SEGMENT DOMINATES THE ENZYME MARKET IN NORTH AMERICA IN 2015
  • FIGURE 49: NEXT-GENERATION SEQUENCERS SEGMENT HOLDS LARGEST SHARE IN THE NORTH AMERICAN INSTRUMENTS AND CONSUMABLES MARKET IN 2015
  • FIGURE 50: ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN NORTH AMERICA IN 2015
  • FIGURE 51: KITS COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN THE U.S. IN 2015
  • FIGURE 52: DNA-MODIFYING ENZYMES TO COMMAND THE LARGEST SHARE IN THE EPIGENETICS ENZYME MARKET IN THE U.S. IN 2015
  • FIGURE 53: NEXT-GENERATION SEQUENCERS TO ACCOUNT FOR THE LARGEST SHARE IN THE EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET IN THE U.S. IN 2015
  • FIGURE 54: ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN THE U.S. IN 2015
  • FIGURE 55: KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN CANADA IN 2015
  • FIGURE 56: DNA-MODIFYING ENZYMES TO COMMAND THE LARGEST SHARE IN THE EPIGENETICS ENZYME MARKET IN CANADA IN 2015
  • FIGURE 57: NEXT-GENERATION SEQUENCERS TO ACCOUNT FOR THE LARGEST SHARE IN THE CANADIAN INSTRUMENTS AND CONSUMABLES MARKET IN 2015
  • FIGURE 58: ONCOLOGY FORMS THE LARGEST RESEARCH AREAS SEGMENT IN CANADA IN 2015
  • FIGURE 59: EUROPE: ECONOMIC INDICATORS
  • FIGURE 60: KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN EUROPE IN 2015
  • FIGURE 61: DNA-MODIFYING ENZYMES SEGMENT TO COMMAND THE LARGEST SHARE IN THE EUROPEAN ENZYME MARKET IN 2015
  • FIGURE 62: NEXT-GENERATION SEQUENCERS SEGMENT HOLDS THE LARGEST SHARE IN THE EUROPEAN INSTRUMENTS AND CONSUMABLES MARKET (2015)
  • FIGURE 63: ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN EUROPE IN 2015
  • FIGURE 64: ASIA: ECONOMIC INDICATORS
  • FIGURE 65: ASIA: MARKET SNAPSHOT
  • FIGURE 66: KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN ASIA IN 2015
  • FIGURE 67: DNA-MODIFYING ENZYMES SEGMENT DOMINATES THE ASIAN MARKET IN 2015
  • FIGURE 68: NEXT-GENERATION SEQUENCERS TO HOLD THE LARGEST MARKET SHARE IN THE ASIAN INSTRUMENTS AND CONSUMABLES MARKET, IN 2015
  • FIGURE 69: ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN ASIA IN 2015
  • FIGURE 70: REST OF THE WORLD: ECONOMIC INDICATORS
  • FIGURE 71: KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN ROW IN 2015
  • FIGURE 72: DNA-MODIFYING ENZYMES WILL DOMINATE ROW MARKET IN 2015
  • FIGURE 73: NEXT-GENERATION SEQUENCERS TO FORM THE LARGEST INSTRUMENT AND CONSUMABLE SEGMENT OF THE ROW MARKET
  • FIGURE 74: ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN ROW IN 2015
  • FIGURE 75: NEW PRODUCT LAUNCHES IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE EPIGENETICS MARKET
  • FIGURE 76: FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
  • FIGURE 77: ABCAM PLC: COMPANY SNAPSHOT
  • FIGURE 78: ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 79: MERCK & CO., INC.: COMPANY SNAPSHOT
  • FIGURE 80: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 81: SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
  • FIGURE 82: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
Back to Top